- Home
- OPTX vs PEPG Comparison
OPTX vs PEPG Comparison
Compare OPTX & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTX
- PEPG
- Stock Information
- Founded
- OPTX 1981
- PEPG 2018
- Country
- OPTX United States
- PEPG United States
- Employees
- OPTX N/A
- PEPG N/A
- Industry
- OPTX Blank Checks
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- OPTX Finance
- PEPG Health Care
- Exchange
- OPTX Nasdaq
- PEPG Nasdaq
- Market Cap
- OPTX 55.8M
- PEPG 52.4M
- IPO Year
- OPTX N/A
- PEPG 2022
- Fundamental
- Price
- OPTX $1.43
- PEPG $1.38
- Analyst Decision
- OPTX
- PEPG Buy
- Analyst Count
- OPTX 0
- PEPG 3
- Target Price
- OPTX N/A
- PEPG $9.67
- AVG Volume (30 Days)
- OPTX 91.9K
- PEPG 228.0K
- Earning Date
- OPTX 05-23-2025
- PEPG 05-08-2025
- Dividend Yield
- OPTX N/A
- PEPG N/A
- EPS Growth
- OPTX N/A
- PEPG N/A
- EPS
- OPTX 0.00
- PEPG N/A
- Revenue
- OPTX $29,392,186.00
- PEPG N/A
- Revenue This Year
- OPTX N/A
- PEPG N/A
- Revenue Next Year
- OPTX N/A
- PEPG N/A
- P/E Ratio
- OPTX $871.00
- PEPG N/A
- Revenue Growth
- OPTX 4.36
- PEPG N/A
- 52 Week Low
- OPTX $0.85
- PEPG $0.88
- 52 Week High
- OPTX $8.39
- PEPG $19.30
- Technical
- Relative Strength Index (RSI)
- OPTX 49.89
- PEPG 46.11
- Support Level
- OPTX $1.43
- PEPG $1.46
- Resistance Level
- OPTX $1.55
- PEPG $1.66
- Average True Range (ATR)
- OPTX 0.08
- PEPG 0.17
- MACD
- OPTX -0.00
- PEPG 0.01
- Stochastic Oscillator
- OPTX 13.04
- PEPG 43.40
About OPTX Syntec Optics Holdings Inc.
Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.